RE: Conclusion - New discussion: PhV in medical research - XXXX [1 Attachment]

[Guest guest]

Dear Sir,

I think the attached file on Pharmacovigilance Protocol mentions about the old

National Pharmacovigilance Programme which ran from 2005-2009 under CDSCO, Govt

of India with WHO support/fund. After 5 yrs were over, WHO has withdrawn the

financial support & also due to lack of ADR feedback from zonal & peripheral

Pharmacovigilance Centres, the National Pharmacovigilance Programme got

defunctional for some period.

Now, as I have heard in different web based forums, the NPP has been relunched

with the name of Pharmacovigilance Programme of India (PVPI), this time wholely

funded by Govt. of India with Dr.Y.K.Gupta as the chief coordinator since July,

2010. Initially it has 10 ADR reporting centres in the 1st phase.

The CDSCO website doesnt yet mention about the new programme but has issued a

recruitment advertisement in the beginning of this year.

Your attached article provides details & framework of the earlier programme. The

details about the new programme (PvPI), I could nt find anywhere.

Regards,

Kaushik Chakraborty

MD (Pharmacology)

Sent from my Nokia E63

Conclusion - New discussion: PhV in medical research - XXXX

[7

>Attachments]

>netrum

>Date: Saturday, 30 October, 2010, 11:05 PM

>

>

>

>Dear members,

>

>With this little discussion of Pharmacovigilance in medical research we come to

>an end.

>

>I would like to conclude my discussion with one request to all especially

>clinicians and pharmacologist - Do report a single ADR which can contribute to

>the development of new signal.

>

>

>The robust pharmacovigilance system is the need of todays medicine because

after

>all SAFETY Matters.

>

>I would like to highlight some of theways to improve the ADR reporting.

Members,

>your suggestions may add a worth information and can help to improve the safety

>of drugs.

>

>- Pharmacovigilance CME / Symposia / Training at frequent intervals in

>healthcare institutions

>- Encouraging patients prescribers and dispensers for their feedback on ADR

>- Establishing separate ADR Monitoring Committee

>- Spreading awareness among all other professionals including Dentist,

>Pharmacist, Nurses, that they could report ADRs

>- More collaborative and meaningful approach in concern to ADR with other

>healthcare professionals

>- Providing information about reporting scheme through journals, meetings,

>symposia, etc.

>- Encouragement institutional head, from local authorities, from the ADR

>Monitoring Committee, from various head of departments, etc.

>- ADR specialist - nominated from each related department

>- On-line or telephone reporting encoraged

>- Educating patients to watch out for possible ADR

>

>Your inputs to this are awaited.

>

>

>Finally, i would like to thank Divya, Dr. Vijay Thawani sir for their valuable

>contribution to the discussion.

>

>Also I am very grateful to Dr. Thawani sir for giving me such a great

>opportunity to moderate this topic. Thanks a lot sir.

>

>For further reading find the attached files.

>

>Regards,

>Dr. Vijay M. katekhaye

>Postgraduate Student

>Dept. of Pharmacology,

>LTMMC & LTMGH, Sion,

>Mumbai - 400 022

>Ph - +919619313060

>